Denis Fortier is a member of the Management Board of Eurobio and General Manager of the Diaxonhit Group. He is particularly in charge of R&D, production, export and business development.
Denis Fortier has more than 25 years of experience in in vitro diagnostics and the biotechnology industry, and has dual experience as a leader and entrepreneur. With a Master’s degree in Biotechnology and Business, he began his career by holding various marketing and commercial positions in diagnostics companies. He became International Director and then Head of Business Development at diagnostics company BMD (now Theradiag). He then joined the General Management of Inodiag, a start-up in the field of diagnostics for infectious diseases, where he was in charge of development and financing. In 2010, he acquired with Jean-Michel Carle Grandmougin the EUROBIO laboratories which he joined as General Manager to oversee production, R&D, business development and export. He is a member of the Entreprendre network, to help start businesses and follow up young entrepreneurs. Denis Fortier owns approximately 15% of DIAXONHIT’s capital.